{"filing":{"accession_number":"0001156375-26-000035","cik":"0001156375","ticker":"CME","company_name":"CME GROUP INC.","form":"8-K","filing_date":"2026-06-10","report_date":null,"primary_document":"cme-20260609.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000035/cme-20260609.htm"},"events":[{"id":5633,"run_id":4936,"accession_number":"0001156375-26-000035","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This Item 5.07 disclosure reports the results of CME Group's 2026 Annual Meeting of Shareholders held on June 9, 2026 (reconvened from May 14 due to quorum issues). The filing details voting outcomes on five substantive proposals: elimination of Class B-1, B-2, and B-3 director election rights (Items 4–6); a certificate of incorporation amendment (Item 7); and election of Class B directors (Item 8). The disclosure includes vote tallies, percentages, and quorum determinations across multiple share classes, which is the core content of a shareholder vote results disclosure under Item 5.07.","company_name":"CME GROUP INC.","ticker":"CME","filing_date":"2026-06-10","form":"8-K","submitted_at":null,"items":[{"id":5937,"accession_number":"0001156375-26-000035","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This Item 5.07 disclosure reports the results of CME Group's 2026 Annual Meeting of Shareholders held on June 9, 2026 (reconvened from May 14 due to quorum issues). The filing details voting outcomes on five substantive proposals: elimination of Class B-1, B-2, and B-3 director election rights (Items 4–6); a certificate of incorporation amendment (Item 7); and election of Class B directors (Item 8). The disclosure includes vote tallies, percentages, and quorum determinations across multiple share classes, which is the core content of a shareholder vote results disclosure under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-10T20:52:08.898507+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5937,"accession_number":"0001156375-26-000035","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This Item 5.07 disclosure reports the results of CME Group's 2026 Annual Meeting of Shareholders held on June 9, 2026 (reconvened from May 14 due to quorum issues). The filing details voting outcomes on five substantive proposals: elimination of Class B-1, B-2, and B-3 director election rights (Items 4–6); a certificate of incorporation amendment (Item 7); and election of Class B directors (Item 8). The disclosure includes vote tallies, percentages, and quorum determinations across multiple share classes, which is the core content of a shareholder vote results disclosure under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-10T20:52:08.898507+00:00","company_name":"CME GROUP INC.","ticker":"CME","filing_date":"2026-06-10"}]}